Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.
about
New virologic tools for management of chronic hepatitis B and CPrevalence and evolution of low frequency HIV drug resistance mutations detected by ultra deep sequencing in patients experiencing first line antiretroviral therapy failureExposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaquesDeep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and proteaseLongitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage TherapyHIV Drug Resistance Mutations (DRMs) Detected by Deep Sequencing in Virologic Failure Subjects on Therapy from Hunan Province, ChinaChallenges and opportunities in estimating viral genetic diversity from next-generation sequencing dataIn vivo mutation rates and the landscape of fitness costs of HIV-1.Validation of an oligonucleotide ligation assay for quantification of human immunodeficiency virus type 1 drug-resistant mutants by use of massively parallel sequencingPerformance of ultra-deep pyrosequencing in analysis of HIV-1 pol gene variation.HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencingNext generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure.Sensitive assessment of the virologic outcomes of stopping and restarting non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.Improved detection of rare HIV-1 variants using 454 pyrosequencing.Comparison of Major and Minor Viral SNPs Identified through Single Template Sequencing and Pyrosequencing in Acute HIV-1 Infection.The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody RecognitionDeep sequencing reveals minor protease resistance mutations in patients failing a protease inhibitor regimen.Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA PopulationsSexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells.Emergent HIV-1 Drug Resistance Mutations Were Not Present at Low-Frequency at Baseline in Non-Nucleoside Reverse Transcriptase Inhibitor-Treated Subjects in the STaR Study.Past, present and future molecular diagnosis and characterization of human immunodeficiency virus infections.Clinical implications of HIV-1 minority variantsDetection of HIV-1 minority variants containing the K103N drug-resistance mutation using a simple method to amplify RNA targets (SMART).Using ultradeep pyrosequencing to study HIV-1 coreceptor usage in primary and dual infection.Clinical, virologic, and immunologic correlates of HIV-1 intraclade B dual infection among men who have sex with men.Dynamics of viral evolution and neutralizing antibody response after HIV-1 superinfection.Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy.A case cluster demonstrating the relationship between HLA concordance and virologic and disease outcomes in human immunodeficiency virus infection.HIV-1 Drug Resistance by Ultra-Deep Sequencing Following Short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for Prevention of Mother-to-Child Transmission.Incidence and prevalence of intrasubtype HIV-1 dual infection in at-risk men in the United States.No Substantial Evidence for Sexual Transmission of Minority HIV Drug Resistance Mutations in Men Who Have Sex with Men.Present and future of molecular monitoring in chronic myeloid leukaemia.Enhanced surveillance of HIV-1 drug resistance in recently infected MSM in the UK.HIV-associated neurocognitive disorder is associated with HIV-1 dual infection.Deep sequencing analysis of HIV-1 reverse transcriptase at baseline and time of failure in patients receiving rilpivirine in the phase III studies ECHO and THRIVE.VirGenA: a reference-based assembler for variable viral genomes.Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc.Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.HIV-TRACE (Transmission Cluster Engine): a tool for large scale molecular epidemiology of HIV-1 and other rapidly evolving pathogens.
P2860
Q27026914-EE42A14E-DFAE-45CF-9238-707EB9F2D105Q28539186-EB4C9EE1-5BF2-49DE-9DCE-059E30A2D12CQ28540200-4A588D47-E427-4768-B857-1AD66FAAE2EFQ28546549-53574BB7-7462-4824-B920-125E7760303FQ28547874-E53F97CD-8E1F-4B1F-9B73-BABC2482FCADQ28550283-FE1859E4-D129-4240-9BE0-C6C4E36BA851Q28727944-06CDEE40-5C33-40FF-9E8E-D654516E5140Q33589204-D9851C78-0274-46B2-923F-B6620A6A3C92Q33899918-BECDB8EB-B58A-4CD2-8A10-25860C84743AQ33974966-078CAA6D-C41F-4EAD-8AA7-7526C5275911Q34657046-EAF47696-8F0E-413F-BD60-BB3DDC1613C1Q34785616-9035C623-C81B-4875-80EC-787ECFF75E84Q34853625-A90ABE00-AA57-46BB-8F41-32101B3B7276Q35009489-DB6EF9CA-861D-4688-BB36-A81746780BE3Q35759184-DDD1D2D9-A19E-45FF-8CB6-E1BFA9BE001AQ35808656-24C7FF66-AFF9-4441-A034-13971306B3ABQ36023047-FB44DA45-481C-403D-92F8-8217CA23916AQ36238501-595A2E73-8667-4200-AA2C-684C0B48B7A0Q36359817-255D0CEF-BAD3-48D6-A647-4B3D31F90202Q36403427-7D6BD452-E6DA-4BB2-A731-413D416CD7D6Q36779718-0027FB6C-AAB2-4ECE-B76F-DFDB8F47D060Q36811249-2F721A9D-907D-4EE4-A0EF-C7BE70824043Q36817632-BC695023-DBD9-425E-9802-867E0FEB019BQ36936363-DD66EA3E-F967-4649-9513-CE42BF71B7BFQ37253688-D89FC110-FEB5-4419-92E7-28F7CC68A0BFQ37336404-BD581ADD-6D60-4109-95C8-5F668E421B05Q37354047-BD6CED85-CE05-4A52-9A38-967CA309EABEQ37492352-585F0852-F43E-4F98-9134-83662B6EB132Q37519808-0D7D16E3-E750-4261-AE64-38930E192E69Q37635156-7DBE6549-CB07-48E7-A8DF-A2205D8657A7Q38644734-D6D4C966-59E6-437A-854D-464373B6787FQ38762631-F5A0B132-3511-432B-9DC8-E6DB6C863BD2Q39289633-81369248-2218-4024-8BA1-571BC093FF62Q40485891-155EAD09-C915-4404-8615-F7318A620C8CQ40978625-457F14C8-3F4A-4572-BDAC-2EBCBED2466CQ41926544-FF67B954-0264-441D-9960-BA2CE1B5FED7Q42255433-C3EB7EE0-EBB1-4823-BA93-8572B4249719Q45979839-21FCE0F1-ADC7-4AB3-AA26-4993B3A3052DQ47140686-8D23F197-C08B-4437-A093-E6D96E266DB4Q50062934-3851C28D-58CD-4648-BE42-C87B3142B4F1
P2860
Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Detection of minority resistan ...... on of multiple viral variants.
@ast
Detection of minority resistan ...... on of multiple viral variants.
@en
type
label
Detection of minority resistan ...... on of multiple viral variants.
@ast
Detection of minority resistan ...... on of multiple viral variants.
@en
prefLabel
Detection of minority resistan ...... on of multiple viral variants.
@ast
Detection of minority resistan ...... on of multiple viral variants.
@en
P2093
P2860
P50
P356
P1433
P1476
Detection of minority resistan ...... ion of multiple viral variants
@en
P2093
Douglas D Richman
Jason A Young
Mary E Pacold
Sara Gianella
Susan J Little
Wayne Delport
P2860
P304
P356
10.1128/JVI.02582-10
P407
P577
2011-06-01T00:00:00Z